Positive News SentimentPositive NewsNASDAQ:ALPN Alpine Immune Sciences (ALPN) News Today $11.45 +0.16 (+1.42%) (As of 09/29/2023 ET) Add Compare Share Share Today's Range$11.30▼$11.5850-Day Range$11.29▼$13.9852-Week Range$4.82▼$14.92Volume404,035 shsAverage Volume253,745 shsMarket Capitalization$563.34 millionP/E RatioN/ADividend YieldN/APrice Target$18.00 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHere's Why You Should Invest in Alpine (ALPN) Stock Nowmsn.com - September 20 at 2:52 AMH.C. Wainwright Keeps Their Buy Rating on Alpine Immune Sciences (ALPN)markets.businessinsider.com - September 13 at 8:33 AMAlpine Immune Sciences Presents First Preclinical Data for Povetacicept in Myasthenia Gravis at the American Neurological Association Annual Meetingfinance.yahoo.com - September 12 at 5:29 PMGreat Point Partners LLC Raises Stock Position in Alpine Immune Sciences, Inc. (NASDAQ:ALPN)marketbeat.com - September 12 at 10:12 AMAlpine Immune Sciences to Present First Preclinical Data for Povetacicept in Myasthenia Gravis at the American Neurological Association Annual Meetingfinance.yahoo.com - September 5 at 8:57 AMAlpine Immune Sciences (NASDAQ:ALPN) Earns "Outperform" Rating from Wedbushmarketbeat.com - September 1 at 4:40 PMAnalyst Expectations for Alpine Immune Sciences's Futuremarkets.businessinsider.com - August 31 at 7:46 PMAlpine Immune Sciences (ALPN) Price Target Increased by 10.67% to 16.93msn.com - August 31 at 7:15 AMAlpine Immune Sciences Announces Initiation of Dosing in 240 mg IgA Nephropathy Cohort of Povetacicept Clinical Study (RUBY-3)finance.yahoo.com - August 30 at 9:15 PMAlpine Immune Sciences, Inc. (ALPN) Is a Great Choice for 'Trend' Investors, Here's Whyfinance.yahoo.com - August 24 at 2:30 PMAlpine Immune Sciences Announces Appointment of M. Christina Yi as Chief Technology Officer and Grant under Nasdaq Listing Rule 5635(c)finance.yahoo.com - August 22 at 5:58 PMDoes Alpine Immune Sciences, Inc. (ALPN) Have the Potential to Rally 25.38% as Wall Street Analysts Expect?finance.yahoo.com - August 17 at 5:27 PMAlpine Immune Sciences: Going Strong But For How Long?msn.com - August 16 at 5:41 PMCompanies Like Alpine Immune Sciences (NASDAQ:ALPN) Are In A Position To Invest In Growthfinance.yahoo.com - August 16 at 8:27 AMSG Americas Securities LLC Acquires New Shares in Alpine Immune Sciences, Inc. (NASDAQ:ALPN)marketbeat.com - August 16 at 4:07 AMHC Wainwright & Co. Maintains Alpine Immune Sciences (ALPN) Buy Recommendationmsn.com - August 15 at 5:25 PMWedbush Maintains Alpine Immune Sciences (ALPN) Outperform Recommendationmsn.com - August 15 at 5:25 PMAlpine Immune Sciences Reports Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 14 at 7:43 PMAlpine Immune Sciences, Inc. (NASDAQ:ALPN) surges 14%; private equity firms who own 38% shares profited along with institutionsfinance.yahoo.com - July 23 at 2:12 PMAlpine Immune Sciences, Inc. (NASDAQ:ALPN) Short Interest Up 26.4% in Junemarketbeat.com - July 17 at 3:23 AMAlpine Immune (ALPN) Stock Up 19% MTD, Will the Uptick Continue?finance.yahoo.com - June 22 at 12:45 PMMetLife Investment Management LLC Purchases New Shares in Alpine Immune Sciences, Inc. (NASDAQ:ALPN)marketbeat.com - June 21 at 4:41 AMAlpine Immune Sciences (ALPN) Receives a Rating Update from a Top Analystmarkets.businessinsider.com - June 14 at 7:34 AMAvidity Partners Management LP Has $7.56 Million Stake in Alpine Immune Sciences, Inc. (NASDAQ:ALPN)marketbeat.com - June 14 at 5:27 AMAlpine Immune Sciences (NASDAQ: ALPN)fool.com - June 10 at 10:48 AMAlpine Immune Sciences to Present Data from RUBY-1, a Phase 1 Study of Povetacicept, at Upcoming Scientific Congressesfinance.yahoo.com - May 19 at 7:37 PMAlpine Immune Sciences GAAP EPS of -$0.28 beats by $0.09, revenue of $9.4M beats by $2.52Mmsn.com - May 13 at 3:58 PMHC Wainwright & Co. Reiterates Alpine Immune Sciences (ALPN) Buy Recommendationmsn.com - May 12 at 7:23 PMRecap: Alpine Immune Sciences Q1 Earningsmsn.com - May 11 at 9:45 PMAlpine Immune Sciences Reports First Quarter 2023 Financial Resultsfinance.yahoo.com - May 11 at 4:45 PMPinning Down Alpine Immune Sciences, Inc.'s (NASDAQ:ALPN) P/S Is Difficult Right Nowfinance.yahoo.com - May 5 at 8:36 AMAlpine Immune Sciences Announces Participation in the Bank of America Securities Healthcare Conferencefinance.yahoo.com - May 1 at 7:43 PMAlpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares Sold by Allspring Global Investments Holdings LLCmarketbeat.com - April 23 at 4:02 AMAlpine Immune Sciences, Inc. (NASDAQ:ALPN) Sees Large Increase in Short Interestmarketbeat.com - April 19 at 4:56 AMAlpine Immune: Rebuilding Itself From Scratch, But Long Way To Go Before Proofseekingalpha.com - March 29 at 7:37 AMAlpine Immune Sciences, Inc. (NASDAQ:ALPN) Q4 2022 Earnings Call Transcriptfinance.yahoo.com - March 27 at 10:30 AMEven though Alpine Immune Sciences (NASDAQ:ALPN) has lost US$39m market cap in last 7 days, shareholders are still up 200% over 3 yearsfinance.yahoo.com - March 27 at 10:30 AMAlpine Immune Sciences, Inc. to Post Q1 2024 Earnings of ($0.41) Per Share, Oppenheimer Forecasts (NASDAQ:ALPN)marketbeat.com - March 27 at 2:38 AMAlpine Immune Sciences Stock (NASDAQ:ALPN), Dividendsbenzinga.com - March 25 at 3:58 PMAlpine Immune Sciences's Return On Capital Employed Insightsmsn.com - March 24 at 2:52 PMQ4 2022 Alpine Immune Sciences Inc Earnings Callfinance.yahoo.com - March 24 at 2:52 PMAlpine Immune Sciences, Inc. (ALPN) Reports Q4 Loss, Lags Revenue Estimatesfinance.yahoo.com - March 23 at 11:50 PMAlpine Immune Sciences Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Resultsfinance.yahoo.com - March 23 at 6:46 PMEarnings Preview: Alpine Immune Sciencesmsn.com - March 22 at 3:00 PMAlpine Immune Sciences to Present Povetacicept (ALPN-303) Phase 1 (RUBY-1) Study Data and Clinical Pharmacokinetic & Pharmacodynamic Modeling at Upcoming Scientific Conferencesfinance.yahoo.com - March 20 at 7:48 PMAlpine Immune Sciences to Present Povetacicept (ALPN-303) Phase 1 (RUBY-1) Study Data at the 2023 American Academy of Dermatology Annual Meetingfinance.yahoo.com - March 16 at 7:55 PMAlpine Immune Sciences to Report Fourth Quarter and Full Year 2022 Financial Resultsfinance.yahoo.com - March 15 at 8:18 PMAlpine Immune Sciences to Participate in Two Upcoming Healthcare Conferencesfinance.yahoo.com - March 1 at 10:21 AMLynx1 Capital Management LP Purchases 1,129,551 Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN)marketbeat.com - February 24 at 1:37 PMShort Interest in Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Declines By 6.6%marketbeat.com - February 17 at 9:26 AM Get Alpine Immune Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ALPN and its competitors with MarketBeat's FREE daily newsletter. Email Address ALPN Media Mentions By Week ALPN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALPN News Sentiment▼1.890.68▲Average Medical News Sentiment ALPN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALPN Articles This Week▼11▲ALPN Articles Average Week Get Alpine Immune Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ALPN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ELVN News CNTA News PHAT News TYRA News BCYC News RAPT News GNLX News DYN News CALT News KURA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:ALPN) was last updated on 9/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpine Immune Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.